Loading…
Smith & Nephew plc is projected to rise to $33.88 by 2027, a +12% move from its current price of $30.21. SNN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $29.79 | $30.20 | $30.62 | -0.03% |
| May 30 | $29.61 | $30.19 | $30.78 | -0.07% |
| May 31 | $29.47 | $30.18 | $30.90 | -0.10% |
| Jun 1 | $29.36 | $30.17 | $31.01 | -0.13% |
| Jun 2 | $29.25 | $30.16 | $31.10 | -0.17% |
| Jun 3 | $29.16 | $30.15 | $31.18 | -0.20% |
| Jun 4 | $29.07 | $30.14 | $31.25 | -0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.07 | $30.14 | $31.25 | -0.23% |
| Week 2 | $28.57 | $30.07 | $31.65 | -0.47% |
| Week 3 | $28.18 | $30.00 | $31.94 | -0.70% |
| Week 4 | $27.84 | $29.93 | $32.17 | -0.93% |
| Week 5 | $27.54 | $29.86 | $32.37 | -1.16% |
| Week 6 | $27.26 | $29.79 | $32.55 | -1.39% |
| Week 7 | $27.01 | $29.72 | $32.70 | -1.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Smith & Nephew plc is a healthcare company that develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
The company also provides sports medicine joint repair products comprising instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.
It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Smith & Nephew plc (SNN) is a healthcare company with current price $30.53 and a market capitalization of $13.01B, ranking 764 by market size. The stock’s price today sits near the forecast 2026 average of $30.53, indicating near-term alignment with expected value.
A major floor 14.1% below — a decisive break under it would weaken the trend.
The nearest floor, 3.7% below — buyers have tended to step in here.
The nearest ceiling, 13.7% above — a clean break opens room to run.
A major ceiling 22.1% above — clearing it would confirm fresh momentum.
Key SNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.59 | Sell | $30.42 | Sell |
| MA 10 | $30.32 | Sell | $30.42 | Sell |
| MA 20 | $30.36 | Sell | $30.68 | Sell |
| MA 50 | $31.74 | Sell | $31.65 | Sell |
| MA 100 | $33.08 | Sell | $32.49 | Sell |
| MA 200 | $34.15 | Sell | $32.62 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.96 | Neutral |
| Stoch RSI (14) | 66.97 | Neutral |
| CCI (20) | -22.08 | Neutral |
| Williams %R (14) | -41.88 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 0.87 | Buy |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 58.12 | Neutral |
| TRIX (15) | -0.28 | Sell |
| Awesome (5,34) | -0.91 | Sell |
| Ultimate (7,14,28) | 56.29 | Neutral |
| Momentum (10) | 0.15 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 30.54 | Sell |
| ADX (14) | 17.80 | Neutral |
| ATR (14) | 0.39 | Info |
The 30-day technical picture is bullish in sentiment. The RSI(14) is 50, with a 50-day simple moving average of $31.85 and a 200-day simple moving average of $34.21. Key near-term levels include support at $29.10 and resistance at $34.36, framing a 30-day range from $27.76 to $33.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.10 | $30.21 | $39.36 | 0% | Neutral | |
| $27.68 | $33.88 | $43.41 | +12% | Neutral | |
| $30.89 | $38.51 | $50.63 | +27% | Bullish | |
| $35.78 | $45.27 | $60.76 | +50% | Bullish | |
| $40.90 | $52.44 | $71.62 | +74% | Bullish | |
| $44.25 | $57.43 | $79.66 | +90% | Bullish | |
| $45.08 | $59.15 | $83.21 | +96% | Bullish | |
| $47.06 | $62.40 | $88.90 | +107% | Bullish | |
| $49.39 | $66.13 | $95.33 | +119% | Bullish | |
| $55.72 | $75.31 | $109.77 | +149% | Bullish | |
| $73.17 | $103.13 | $157.47 | +241% | Bullish | |
| $154.15 | $232.98 | $381.22 | +671% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $29.10 | $30.21 | $35.35 | +0.00% |
| June 2026 | $25.48 | $29.73 | $35.35 | -1.59% |
| July 2026 | $24.98 | $29.30 | $35.18 | -1.43% |
| August 2026 | $25.38 | $29.91 | $36.17 | +2.08% |
| September 2026 | $25.53 | $30.20 | $36.73 | +0.96% |
| October 2026 | $25.21 | $29.92 | $36.59 | -0.91% |
| November 2026 | $25.69 | $30.59 | $37.58 | +2.22% |
| December 2026 | $26.71 | $31.89 | $39.36 | +4.25% |
Click any year to see its month-by-month SNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Smith & Nephew plc's 2026 outlook centres on $30.21, within a $29.10 to $39.36 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNN could reach as high as $43.41, with a base case around $33.88 and support toward $27.68 — roughly +12% from $30.21. A consolidation phase looks the most probable path here.
Expect SNN to range from $30.89 to $50.63 through 2028. The $38.51 average target implies a +27% move from current prices. That is up +14% on the projected 2027 average. Momentum favours further upside here.
The SNN price prediction for 2029 points to an average of $45.27 (low $35.78, high $60.76) — a potential gain of +50% on today's $30.21. Buyers look set to stay in control over this stretch.
In 2030, SNN is projected to trade between $40.90 and $71.62, averaging $52.44 — a potential gain of +74% from today's $30.21. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Smith & Nephew plc's 2031 outlook centres on $57.43, within a $44.25 to $79.66 range. That is up +10% on the projected 2030 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SNN could reach as high as $83.21, with a base case around $59.15 and support toward $45.08 — roughly +96% from $30.21. Momentum favours further upside here.
Expect SNN to range from $47.06 to $88.90 through 2033. The $62.40 average target implies a +107% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNN price prediction for 2034 points to an average of $66.13 (low $49.39, high $95.33) — a potential gain of +119% on today's $30.21. Momentum favours further upside here.
In 2035, SNN is projected to trade between $55.72 and $109.77, averaging $75.31 — a potential gain of +149% from today's $30.21. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Smith & Nephew plc's 2040 outlook centres on $103.13, within a $73.17 to $157.47 range. That is up +37% on the projected 2035 average. That marks a +241% change versus current levels. Momentum favours further upside here.
By 2050, SNN could reach as high as $381.22, with a base case around $232.98 and support toward $154.15 — roughly +671% from $30.21. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNN today (≈ 33.101622 SNN) could be worth
$7,712
+$6,712 (+671%) by 2050 · US Dollar
Based on the average projected SNN price of $232.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNNwould be worth at today's price.
$1,000 invested in SNN on May 27, 2025 (≈ 34.578147 SNN) would be worth
$1,044.61
+$44.61 (+4.5%) today · 1.04× · US Dollar
Based on a SNN entry price of $28.92 vs. today's $30.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $31.01 | $974.2 | -2.6% |
| 1 month ago | $32.09 | $941.41 | -5.9% |
| 3 months ago | $36.68 | $823.61 | -17.6% |
| 6 months ago | $33.28 | $907.75 | -9.2% |
| 1 year ago | $28.92 | $1,044.61 | +4.5% |
| All time (5.0y) ago | $43.19 | $699.47 | -30.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNN forecast.
Our base-case forecast reaches $60.00 around 2033.
Implied market cap at $60.00: $25.53B
The multi-year forecast shows meaningful upside beyond 2026. Notably, the 2030 forecast implies an average price of $54.71 with a 79.2% ROI and a bullish sentiment, while the 2040 forecast presents an average of $111.74 with a 266% ROI and a bullish stance. The 2050 forecast projects an average of $255.40 with a 736.5% ROI and a bullish outlook.
In between, 2027, 2028, 2029, and 2035 show progressive gains, reinforcing a long-run upward trajectory. These figures are estimates and not guarantees, and actual results will depend on many factors. The implied price path carries substantial upside risk as well as potential drawdowns in shorter horizons.
Tap a question to reveal the answer.
Avg $54.71; min $42.66; max $74.75; ROI 79.2%; sentiment BULLISH.
Forecasts show rising averages beyond 2026, with 2027 Avg $34.57, 2028 Avg $40.02, 2029 Avg $47.40, 2030 Avg $54.71, and 2050 Avg $255.40, with corresponding ROIs up to 736.5%, indicating potential long-term upside alongside uncertainty.
Yes—the 2040 max is $170.63, with 2035 max $117.73 and 2050 max $417.93, indicating the potential to surpass $170 by 2040 according to the forecast.
Current price $30.53; Market cap $13.01B.
30-day range low $27.76; high $33.58.
Smith & Nephew plc Community Discussion
0Share your Smith & Nephew plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.